MedPath

Meclofenamic acid

Generic Name
Meclofenamic acid
Drug Type
Small Molecule
Chemical Formula
C14H11Cl2NO2
CAS Number
644-62-2
Unique Ingredient Identifier
48I5LU4ZWD

Overview

A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.

Background

A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.

Indication

For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis.

Associated Conditions

  • Acute Gouty Arthritis
  • Ankylosing Spondylitis (AS)
  • Fever
  • Hypermenorrhea
  • Juvenile Idiopathic Arthritis (JIA)
  • Mild pain
  • Osteoarthritis (OA)
  • Primary Dysmenorrhoea
  • Rheumatoid Arthritis
  • Acute Subacromial bursitis
  • Moderate Pain
  • Supraspinatus tendinitis

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Mylan Pharmaceuticals Inc.
0378-2150
ORAL
50 mg in 1 1
3/12/2021
Mylan Pharmaceuticals Inc.
0378-3000
ORAL
100 mg in 1 1
3/12/2021

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath